Research Articles

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.

Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.

Tavul L, Laman M, Howard C, Kotty B, Samuel A, Bjerum C, O'Brian K, Kumai S, Amuga M, Lorry L, Kerry Z, Kualawi M, Karl S, Makita L, John LN, Bieb S, Wangi J, Weil GJ, Goss CW, Tisch DJ, Pomat W, King CL, Robinson LJ

Cell biological analysis reveals an essential role for Pfcerli2 in erythrocyte invasion by malaria parasites.

Liffner B, Balbin JM, Shami GJ, Siddiqui G, Strauss J, Frölich S, Heinemann GK, Edwards EM, Alder A, Wichers JS, Creek DJ, Tilley L, Dixon MWA, Gilberger TW, Wilson DW

[Potential challenges for large-scale uses of RTS, S/AS01 vaccine in malaria-endemic areas].

Feng GQ

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis.

Liu H, Pietersz G, Peter K, Wang X

Economic burden of female genital mutilation in 27 high-prevalence countries.

Tordrup D, Bishop C, Green N, Petzold M, Ruiz Vallejo F, Vogel JP, Pallitto C

Maternal, Newborn + Child Health